VASUNDHARA RASAYANS LTD
VRL (BSE 538634) · ISIN INE406F01010 · Pharmaceuticals · Est. 1987 · listed 2014 · website
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹40.88 cr | ₹1.81 cr | ₹47.88 cr |
| 30 Sep 2025 standalone | ₹39.11 cr | ₹5.34 cr | ₹48.15 cr |
| 31 Mar 2025 standalone | ₹35.56 cr | ₹4.21 cr | ₹43.07 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 61.98% | — | — | 38.02% |
Latest filings
- Scrutinizer''s Report on the remote e-voting as well as e-voting (Insta-Poll) during the AGM, issued by Mrs. Rakhi Agarwal, Practising Company secretary, Scrutinizer 27 August 2026 · BSE
- Summary of proceedings of the 39th Annual General Meeting of the Company is attached 25 August 2026 · BSE
- Financial Results for the quarter ended 30.06.2026 14 August 2026 · BSE
- Approved the Un-audited Financial Results of the Company for the quarter ended on 30th June, 2026, and Limited Review Report, pursuant to Regulation 33 of the SEBI (Listing Obligations .... 14 August 2026 · BSE
- Annual Report FY2025-26 (New) 1 August 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.